1. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis*. (1st June 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis. (1st June 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis. (22nd February 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Methotrexate vs. fumaric acid esters in moderate‐to‐severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions. (2nd June 2012) Authors: Inzinger, M.; Weger, W.; Heschl, B.; Salmhofer, W.; Quehenberger, F.; Wolf, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 27:Number 7(2013:Jul.) Page Start: 861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions. (1st September 2015) Authors: Painsi, C.; Patscheider, M.; Inzinger, M.; Huegel, R.; Lange‐Asschenfeldt, B.; Quehenberger, F.; Wolf, P. Journal: British journal of dermatology Issue: Volume 173:Number 3(2015:Sep.) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions. (22nd July 2015) Authors: Painsi, C.; Patscheider, M.; Inzinger, M.; Huegel, R.; Lange‐Asschenfeldt, B.; Quehenberger, F.; Wolf, P. Journal: British journal of dermatology Issue: Volume 173:Number 3(2015:Sep.) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions. (22nd July 2015) Authors: Painsi, C.; Patscheider, M.; Inzinger, M.; Huegel, R.; Lange‐Asschenfeldt, B.; Quehenberger, F.; Wolf, P. Journal: British journal of dermatology Issue: Volume 173:Number 3(2015:Sep.) Page Start: 815 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Short‐ to intermediate‐term follow‐up in patients treated with the combination of 311‐nm ultraviolet B phototherapy and biological agents. (1st October 2014) Authors: Inzinger, M.; Legat, F.J.; Hofer, A.; Weger, W.; Gruber‐Wackernagel, A.; Salmhofer, W.; Wolf, P. Journal: British journal of dermatology Issue: Volume 171:Number 4(2014:Oct.) Page Start: 915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Short‐ to intermediate‐term follow‐up in patients treated with the combination of 311‐nm ultraviolet B phototherapy and biological agents. (5th August 2014) Authors: Inzinger, M.; Legat, F.J.; Hofer, A.; Weger, W.; Gruber‐Wackernagel, A.; Salmhofer, W.; Wolf, P. Journal: British journal of dermatology Issue: Volume 171:Number 4(2014:Oct.) Page Start: 915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Short‐ to intermediate‐term follow‐up in patients treated with the combination of 311‐nm ultraviolet B phototherapy and biological agents. (5th August 2014) Authors: Inzinger, M.; Legat, F.J.; Hofer, A.; Weger, W.; Gruber‐Wackernagel, A.; Salmhofer, W.; Wolf, P. Journal: British journal of dermatology Issue: Volume 171:Number 4(2014:Oct.) Page Start: 915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗